Mr. Divecha is the head of GMO’s Emerging Markets Equity team and Chairman of the GMO Board of Directors. Prior to joining GMO in 1993, he spent 12 years at BARRA directing software development, marketing, client service and emerging markets research and development. Mr. Divecha holds a Bachelor of Technology in Aeronautical Engineering from the Indian Institute of Technology, Bombay and an MBA in Finance from Cornell University.
Mr. Casper is a member of the GMO Board of Directors. He has more than thirty years’ experience in the financial services industry which includes senior leadership roles at The Rohatyn Group, Vastardis Capital Services, Fischer Francis Trees & Watts, Inc., and the Rockefeller Family Office. He is currently the Lead Independent Director at MarketAxess Holdings and serves on the Boards of the KLS Funds, the Alzheimer Association’s New York City Chapter and the Brooklyn Museum, where he is also a member of the Investment Committee. He was previously on the Board of the Depository Trust and Clearing Corporation. Mr. Casper holds a B.B.A. from Baruch College of the City University of New York and an M.S. in Finance and Accounting from the Wharton School of Business.
Ms. Drucker is a member of the GMO Board of Directors. In the course of over three decades in investment management, Ms. Drucker’s experience includes early work in the field of quantitative investing, followed by senior roles and/or CIO positions at International Paper, Xerox and General Motors Asset Management. She served as the Chair of the Commonfund Board, and is currently a member of the Board of Directors and Investment Committees for several organizations. Ms. Drucker has a B.A. in Literature and Psychology from Sarah Lawrence College.
Mr. Grantham co-founded GMO in 1977 and is a member of GMO’s Asset Allocation team, serving as the firm’s chief investment strategist. Prior to GMO’s founding, Mr. Grantham was co-founder of Batterymarch Financial Management in 1969 where he recommended commercial indexing in 1971, one of several claims to being first. He began his investment career as an economist with Royal Dutch Shell. He is a member of the GMO Board of Directors and has also served on the investment boards of several non-profit organizations. He earned his undergraduate degree from the University of Sheffield (U.K.) and an MBA from Harvard Business School.
Mr. Hilsabeck is the Chief Executive Officer of GMO and a member of the GMO Board. He became a GMO partner at the end of 2005 and joined GMO’s Executive Committee in 2006. Mr. Hilsabeck then served as a member of GMO’s Executive Office until 2009, after which he became a member of GMO’s Leadership Council. He has also been a member of GMO’s Partnership Committee since 2010. Immediately prior to joining GMO, he was a senior principal at State Street Global Advisors. Mr. Hilsabeck earned his B.A. from Westminster College in Missouri.
Mr. Inker is co-head of GMO’s Asset Allocation team and member of the GMO Board of Directors. In addition, he oversees the Developed Fixed Income team. He joined GMO in 1992 following the completion of his B.A. in Economics from Yale University. In his years at GMO, Mr. Inker has served as an analyst for the Quantitative Equity and Asset Allocation teams, as a portfolio manager of several equity and asset allocation portfolios, as co-head of International Quantitative Equities, and as CIO of Quantitative Developed Equities. He is a CFA charterholder.
Ms. McGetrick is a member of the GMO Board of Directors. Ms. McGetrick is a founding partner of Liberty Square Asset Management and portfolio manager. In her previous employment with GMO from 1984 to 1996, she led the International Active Equity division and was also partner of the firm. Ms. McGetrick began her investment career in non-U.S. equities in 1982 as an analyst for The Commonfund for International Investments. She serves on the Investment Committee of Partners Healthcare System, Providence College, and The Wheeler School. Ms. McGetrick graduated from Providence College with a Bachelor of Science degree in Psychology and Business Management, and holds a Master’s of Science degree in Finance from Fairfield University.
Dr. Rosenblum is a member of the GMO Board. Previously, he was the dean of Jepson School of Leadership Studies at the University of Richmond. Prior to that, he taught at the Harvard Business School and was dean of the Darden School at the University of Virginia. Dr. Rosenblum earned his A.B. in Mathematics and Economics from Brown University and his M.B.A. and D.B.A. from Harvard University.